Beqalzi (Sonrotoclax)

Beqalzi (sonrotoclax) is a BCL-2 inhibitor indicated for the treatment of adult patients with relapsed or refractory mantle cell lymphoma (MCL) after at least two lines of systemic therapy, including a Bruton’s tyrosine kinase (BTK) inhibitor.

This indication is approved under accelerated approval based on response rate and durability of response. Continued approval for this indication may be contingent upon verification and description of clinical benefit in a confirmatory trial(s).

Recommended Dosage:
The recommended dosage of Beqalzi should be taken exactly as prescribed by your healthcare provider. The medicine should be taken once daily with a meal, preferably at the same time each day. Swallow the tablets whole with a glass of water. It is not advisable to break, crush, or chew the tablets.

If you miss a dose, follow your healthcare provider’s instructions or the product guidance regarding missed doses. In case of vomiting after taking the medicine, do not take an additional dose on the same day unless advised by your doctor.

Always consult your physician for the appropriate dosage and treatment schedule based on your medical condition.

• Treatment with Beqalzi tablets may be responsible for increasing the risk of tumor lysis syndrome, particularly in patients with high tumor burden. Adequate hydration, laboratory monitoring, and preventive treatment should be considered before starting therapy to reduce complications involving electrolyte imbalance, renal dysfunction, and other conditions.
• Serious and sometimes fatal infections may develop during treatment with this medicine due to immune suppression. Patients should be monitored for fever, respiratory symptoms, or signs of infection throughout therapy. Treatment interruption or antimicrobial management may be necessary in some cases.
• Therapy with this medicine may cause neutropenia, increasing susceptibility to bacterial, viral, and fungal infections. Monitored complete blood counts (CBC) regularly during treatment. Dose modification, temporary interruption, or supportive care may be required in patients developing serious or prolonged neutropenia symptoms.
• This medicinal product may cause fetal harm when administered during pregnancy based on its mechanism of action. Women of reproductive age should use an effective contraception method during treatment and after the final dose. Patients should inform their doctors if pregnancy develops unexpectedly.
• Do not breastfeed during treatment with Beqalzi and for a period after the final dose because of the potential risk of serious side effects in breastfed infants. Patients should discuss feeding options with their clinician before therapy.

What documents are required to import BEQALZI to India?

BEQALZI (sonrotoclax) tablets may be imported by patients or government hospitals in the patients’ names only.
The following documentation is required to import the product:

• A valid prescription from a qualified doctor.
• Patients diagnostic reports
• Patient ID proof (issued by the government of India)

How does the order get confirmed?

The order will be confirmed only after the receipt of:

• A valid prescription from the Doctor
• Import permit if applicable

Is BEQALZI available in India?

BEQALZI (sonrotoclax tablets) is a (prescription drug, prescription medication, or prescription medicine) pharmaceutical drug that legally requires a medical prescription to be dispensed.

IPN (Indian Pharma Network) facilitates the import of cancer medicines under named patient supply (NPS). Indian Pharma Network is the facilitator, providing input

• On the availability of Beqalzi in India (Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Pune, etc.)
• On availability in Gulf countries (Bahrain, Oman, Qatar, Kuwait, Iraq, Saudi Arabia, and the UAE).
• Beqalzi price in India.
• Finding Genuine and reliable sources from the USA, Canada, Europe, and Australia
• Ensuring 100% transparency.

BEQALZI can be made available to patients, doctors, and hospitals in Mumbai, Goa, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Srinagar, Jammu, Jaipur, Chandigarh, Ludhiana, Noida, Gurgaon, Lucknow, and Pune, as well as other cities in India. The order will be confirmed only after the receipt of a valid prescription from the doctor and an import permit.

IPN (Indian Pharma Network) can facilitate the supply of BEQALZI (prescription medicines) to all locations in the world and India after fulfilling the legal requirements (if applicable).

Please contact us at WhatsApp: +91 98104 69557 | Toll-Free Number: 1800-1200-365 or write us at info@indianpharmanetwork.in for Beqalzi cost in India.

We guarantee quality and delivery anywhere in the world as per the buyer’s requirements.

Indian Pharma Network can source BEQALZI (Cancer Treatment Medicines) from across the globe and can supply. Indian Pharma offers its customers worldwide access to the best available treatment.

Indian Pharma Network (IPN) can dispense any valid prescription in the shortest possible time. All prescriptions are dispensed and checked by registered pharmacists and dispatched to the Patient’s address only from New Delhi, India.

What is the Generic Name for the trade name drug Beqalzi®?

Sonrotoclax is the Generic Name for the trade name drug Beqalzi®.

What is the Manufacturer’s Name of Beqalzi®?

Beqalzi® is manufactured by BeOne Medicines Ltd.

Is Beqalzi® approved by the FDA?

Yes. Beqalzi® is approved by the FDA. Date of first approval: May 13, 2026.

What strengths and dosage forms are available for Beqalzi®?

Beqalzi® is available as Tablets: 1 mg, 5 mg, 20 mg, and 80 mg for oral administration.

What are the most common side effects of Beqalzi® Tablets?

The most commonly reported side effects of Beqalzi are pneumonia and fatigue.

What is the availability of Beqalzi near Medanta Hospital in Gurgaon?

Patients receiving treatment near Medanta Hospital can buy Beqalzi through a patient-specific import pathway. With a valid doctor’s prescription, the treatment can be arranged and delivered directly to the hospital in Gurgaon.

What is the availability of Beqalzi in Bangalore?

Beqalzi in Bangalore is not yet commercially marketed, but patients can still access it through regulated import provisions. Once prescribed by a treating clinician, the medicine is sourced internationally and supplied to the treating hospital.

Is Beqalzi available at HCG Cancer Centre, Bangalore?

Beqalzi may not be routinely stocked in India. However, it can be accessed through a Named Patient Program (NPP) with a valid prescription from a doctor at the hospital. Indian Pharma Network (IPN) can help facilitate the import of Beqalzi at HCG Cancer Centre, Bangalore.

What is the availability of Beqalzi in Mumbai?

The patient can buy Beqalzi in Mumbai via special access programs that allow the import of approved international medicines. The treatment is delivered to the hospital where the patient is undergoing care.

I want to buy Beqalzi in Mumbai. How can I access it?

If you are looking to buy Beqalzi in Mumbai, the first step is consultation with your doctor. Once prescribed, the medicine can be sourced from global suppliers through a compliant import process and delivered to your treating hospital.

What is the availability of Beqalzi in Chennai?

Patient access to Beqalzi in Chennai is possible through special access programs such as Named Patient Programs (NPP), which allow the import of internationally approved medicines. The treatment is arranged and delivered directly to the hospital where the patient is receiving care, ensuring compliance with regulatory requirements.

I want to buy Beqalzi in Chennai. How can I access it?

If you are looking to buy Beqalzi in Chennai, the first step is to consult your doctor. Upon prescription, the medicine can be sourced from global suppliers through a compliant import process under NPP and delivered to your treating hospital, such as Apollo Hospitals Chennai or Cancer Institute (WIA).

What is the availability of Beqalzi in Hyderabad?

Beqalzi is accessible in Hyderabad through special access programs like Named Patient Programs (NPP), which enable the legal import of medicines not widely available in India. The medication is delivered directly to the hospital where the patient is undergoing treatment.

I want to buy Beqalzi in Hyderabad. How can I access it?

To access Beqalzi in Hyderabad, patients should first consult their doctor. Once prescribed, the medicine can be arranged through authorized channels under NPP guidelines and delivered to the treating hospital, such as Basavatarakam Indo-American Cancer Hospital.

I want to buy Beqalzi in Bangalore. How can I access it?

Patients seeking access to Beqalzi in Bangalore should consult their doctor for evaluation and prescription. Following this, the medicine can be procured through compliant import channels and delivered to the treating hospital, such as HCG Cancer Center and Fortis Hospital, Bangalore.

I want to buy Beqalzi in Gurgaon. How can I access it?

Patients looking to buy Beqalzi in Gurgaon should consult their doctor for evaluation and prescription. Following this, the medicine can be procured through compliant import channels and delivered to the treating hospital, such as Medanta – The Medicity, Artemis Hospitals, Fortis Hospital, and Max Hospital, Gurgaon.

Can I buy Beqalzi at major hospitals like AIIMS, Sir Ganga Ram, Apollo, or Fortis?

Beqalzi can be accessed at leading hospitals such as AIIMS Delhi, Medanta – The Medicity, Sir Ganga Ram Hospital, Apollo Hospitals Chennai, Christian Medical College (CMC), PGIMER, Amrita Hospital, Artemis Hospital, Safdarjung Hospital, Kauvery Hospital, Sri Ramachandra Medical Centre, MIOT International, SCTIMST, NIMS Hospital, KIMS Hospitals, AIG Hospitals, Bombay Hospital, Lilavati Hospital, Care Hospitals, Narayana Health City, Jaslok Hospital, Yashoda Hospitals, Fortis Memorial Research Institute, Kokilaben Dhirubhai Ambani Hospital, P. D. Hinduja Hospital, Manipal Hospitals, Aster Medcity, Indraprastha Apollo Hospital, King George’s Medical University (KGMU), Shalby Hospitals, Tata Memorial Centre, HCG Cancer, Basavatarakam Indo-American Cancer Hospital, Cancer Institute (WIA), Max Healthcare, and Rajiv Gandhi Cancer Institute & Research Centre through the Named Patient Program (NPP) with a valid doctor’s prescription. Indian Pharma Network assists with import and delivery to the treating hospital.

How does Beqalzi Import in India work?

Beqalzi Import in India is possible through the Named Patient Program. This means the medicine can be imported for a specific patient with a valid doctor’s prescription. Indian Pharma Network helps manage the complete process, including approvals and delivery, making sure the medicine reaches the patient safely and legally.

Who is a reliable Beqalzi supplier in India?

Indian Pharma Network is a trusted Beqalzi supplier in India, facilitating compliant access through global sourcing channels and structured documentation support for eligible patients under applicable regulatory provisions.

How much does Beqalzi cost in India?

Beqalzi is not yet approved in India. However, patients in India can legally access it through the Named Patient Program (NPP). Beqalzi prices may fluctuate over time because of market dynamics and regulatory changes. For the most transparent and latest Beqalzi cost in India, please call/WhatsApp +91 98104 69557 or send an email to info@indianpharmanetwork.in.

Can Beqalzi be available in SAARC countries?

Apart from Gulf countries, Beqalzi can be accessed through import provisions like the Named Patient Program (NPP) in SAARC countries (India, Afghanistan, Maldives, Nepal, Bangladesh, Bhutan, Pakistan, and Sri Lanka). Indian Pharma Network (IPN) can help facilitate the legal supply of Beqalzi in these countries. We help provide legal access to this therapeutic drug through our reliable channels.

Is it safe to buy Beqalzi online in India?

Yes, one can buy Beqalzi in India at the lowest price from the Indian Pharma Network (IPN) if this medicinal product is not yet registered or available in their country. We can help facilitate the supply of Beqalzi through legal channels.

Where can Beqalzi be shipped in India?

We can assist patients and healthcare providers in accessing Beqalzi across major cities and states in India through the Named Patient Program (NPP).
We can ship Beqalzi in Ahmedabad, Amritsar, Aurangabad, Bangalore, Bhopal, Bhubaneswar, Chandigarh, Chennai, Coimbatore, Dehradun, Delhi, Faridabad, Ghaziabad, Goa, Gurgaon, Guwahati, Hyderabad, Indore, Jaipur, Jammu Kashmir, Kanpur, Kochi, Kolkata, Lucknow, Ludhiana, Madurai, Mangalore, Mumbai, Mysore, Nagpur, Nashik, Navi Mumbai, Noida, Patna, Pune, Raipur, Ranchi, Surat, Thane, Trivandrum, Vadodara, Varanasi, Vijayawada, Visakhapatnam, and other cities across India.

Who is an authorized Beqalzi importer in India?

Indian Pharma Network acts as the Beqalzi importer in India, assisting with Named Patient Import processes, regulatory documentation, and compliant international procurement for patients requiring this therapy.

In which countries is Beqalzi approved?

Beqalzi (sonrotoclax) has been approved in China and the United States. It is approved for the treatment of specific blood cancers, including relapsed or refractory mantle cell lymphoma (MCL).

Can I buy Beqalzi from Europe, the USA, or other countries?

As of now, Beqalzi is approved and available in the U.S. and China, but patients in India cannot directly buy it from abroad. It can be legally accessed through the Named Patient Program (NPP) with a valid prescription. Indian Pharma Network assists with compliant sourcing and delivery to the treating hospital.

What are the storage conditions of Beqalzi® Tablets?

Store the tablets at 20°C to 25°C (68°F to 77°F); excursions permitted between 15°C and 30°C (59°F and 86°F).